Posted by keown83 > 2020-12-10 22:47 | Report Abuse

its still closing within 1.70 which for me is pretty good retracement..hold tight OK..just set ur exit within 1.60 region if things going south

Posted by NPRA1985 > 2020-12-10 23:59 | Report Abuse

Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.

“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.

“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.

SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.

https://asiatimes.com/2020/12/uae-gives-chinese-vaccines-a-shot-in-the-arm/

Posted by Mosiong Wong > 2020-12-11 00:34 | Report Abuse

Yes

Posted by jack64r > 2020-12-11 09:12 | Report Abuse

If strong buying support, I won't be surprise if today can be a start of a new run. If close green today all indication next week will fly.

Posted by Snowpiercer > 2020-12-11 10:03 | Report Abuse

Unfortunately post FY 2021, results will drop substantially for all glove companies. Profitability is not only on asp and sales

Posted by Nicolas Nelson Ong > 2020-12-11 10:55 | Report Abuse

Sorry kids i have try my best to hold the line but the selling strenght tooo strong ..... i habe acquire 80,000,000 shares but players still selling thier tickets ....good luck and take care

Posted by ryanlcc > 2020-12-11 14:51 | Report Abuse

Brewing like coffee..
Chill dulu okay?
dont kan cheong..

Posted by opportunity > 2020-12-11 15:13 | Report Abuse

rubberex also mau vaccine mou

Posted by kasrim > 2020-12-11 15:38 | Report Abuse

ini maciam sy tunggu rm 1.00 baru avrg down

Posted by opportunity > 2020-12-11 15:57 | Report Abuse

VVIP is collecting vastly in 1.68. go check

Posted by VTrade > 2020-12-11 16:26 | Report Abuse

TP is 1.50 gogogo

Posted by NPRA1985 > 2020-12-11 16:30 | Report Abuse

I think institutions have already mostly withdrawn from glove counters and moved on the recovery theme counters leaving mostly retailers in the glove counters. Please correct me if am wrong...

Posted by Nicolas Nelson Ong > 2020-12-11 16:31 | Report Abuse

Opps yes i am collecting it pls dont explore it to everyone. Its very tired to hold the price ...hope everyone here can help to hold rhe price ...i have acquired 300,000,000 shares at 1.68

Posted by roshazli > 2020-12-11 16:39 | Report Abuse

Fact box: When and which Covid-19 vaccines are likely to be available in Asia

BEIJING/TOKYO/SEOUL/MANILA/TAIPEI/JAKARTA/DHAKA/HANOI (Dec 11): Trial data from Pfizer Inc with partner BioNTech SE, Moderna Inc and AstraZeneca Plc has shown their experimental vaccines are effective in preventing novel coronavirus infection.
While regulatory processes are underway, few Asian countries expect to receive significant amounts of the vaccines initially. Here are estimated distribution time lines, supply deals announced and clinical trials being held in the region.

Australia
The country has secured around 140 million doses: 53.8 million from AstraZeneca, 51 million from Novavax Inc, 10 million from Pfizer, and 25.5 million from distribution programme COVAX.
It expects delivery of 3.8 million doses of AstraZeneca's vaccine in January and February next year and plans to begin inoculations in March.

China
China has not announced supply deals with Western drugmakers, which instead have partnered with private companies in the country.AstraZeneca's vaccine may be approved in China by mid-2021 and its Chinese partner Shenzhen Kangtai Biological Products Co Ltd plans annual production capacity of at least 100 million doses by the end of this year.
For the Pfizer/BioNTech vaccine, a unit of Shanghai Fosun Pharmaceutical Group Co Ltd plans a Phase II trial.
Tibet Rhodiola Pharmaceutical Holding Co is bringing in Russian vaccine candidate Sputnik V and plans early and mid-stage trials in China.
China has also approved three vaccine candidates developed by Sinovac Biotech Ltd and state-owned China National Pharmaceutical Group (Sinopharm) for emergency use, and Sinopharm hopes its two candidates will get conditional approval for general use this year.

Japan
Japan has deals to buy 120 million doses from Pfizer/BioNTech in the first half of next year and 120 million from AstraZeneca - the first 30 million of which will be shipped by March 2021 - and 250 million from Novavax.
It is also in talks with Johnson & Johnson and has a deal with Shionogi & Co Ltd.
Experts said vaccine makers would need to conduct at least Phase I and II trials in Japan before seeking approval for use.

South Korea
The country has deals to buy 20 million doses each from AstraZeneca, Pfizer and Moderna and another 4 million doses from Johnson & Johnson's Janssen, enough to cover up to 34 million people.It will procure additional doses for 10 million people through COVAX.Inoculation is likely to start in the second quarter of next year to allow time to observe possible side effects.

India
The head of the Serum Institute of India, which makes the AstraZeneca vaccine, said on Nov. 23 the positive late-state trial result of the candidate will allow it to seek emergency use approval by year-end, before securing approval for full introduction by February or March.
India also expects a government-backed vaccine to be launched as early as February. It is also conducting a late-stage trial of Sputnik V.

Taiwan
Taiwan aims to secure around 15 million doses initially, both via the COVAX scheme and by direct purchases from manufacturers, and may buy an additional 15 million doses.
The government has said it hopes to begin vaccinations in the first quarter next year.

Malaysia
The Southeast Asian nation has agreed to buy 12.8 million doses of the Pfizer vaccine, becoming the first country in the region to announce a deal with the U.S. drugmaker after some expressed reservations over the need for the ultra-cold storage that the vaccine requires.
Pfizer will deliver the first batch of 1 million doses in the first quarter of next year.

The Philippines
The archipelago announced a deal on Nov. 27 for 2.6 million doses of the AstraZeneca vaccine and is discussing a possible 1 million more, covering about 1% of a population of 108 million people.It is also seeking 20 million to 50 million doses from Sinovac and is in talks with others, including Pfizer.Vaccine makers can seek approval from Philippine regulators even if no clinical trial is conducted in the country.

Indonesia
Southeast Asia's most populous country has secured 125.5 million doses from Sinovac, 30 million from Novavax, is in talks with AstraZeneca and Pfizer to buy 50 million doses each, and expects to get 16 million from COVAX.Indonesia is testing Sinovac's vaccine and preparing mass vaccination for medical staff and other frontline workers to start as soon as late January.

Vietnam
A government official said COVAX vaccines would cover only 20% of the population and the country is likely to have a chance to secure separate deals soon, as demand is very high.

Bangladesh
Bangladesh signed a deal with India's Serum Institute to buy 30 million doses of the AstraZeneca vaccine.It also expects to receive 68 million doses from global vaccine alliance GAVI at a subsidised rate, a senior health ministry official said.

Posted by kens88 > 2020-12-11 17:40 | Report Abuse

Cut loss 1.65?

Posted by Thomasyow > 2020-12-11 17:50 | Report Abuse

Now all big sharks go fry other stocks.
Need to wait big sharks come back glove stock.
Average down at 1.6. (Big support)

Posted by darkfire2313 > 2020-12-11 18:24 | Report Abuse

Despite record earnings, the sentiment currently has moved towards recovery play. The possibility of it reaching TP calculated by IBs seems highly improbable, no? Maths does not seem to work any more in the market. The whole market is illogical.

Posted by Shadows > 2020-12-11 22:29 | Report Abuse

https://www.theedgemarkets.com/article/sanofi-gsk-announce-delay-covid19-vaccine-project
Vaccine setback.

Posted by gemfinder > 2020-12-11 22:47 |

Post removed.Why?

Posted by Joyce Lee > 2020-12-12 00:36 | Report Abuse

Gemfinder diam la u , day day cursing others losing money

Posted by MasterYoda > 2020-12-12 01:10 | Report Abuse

https://www.theedgemarkets.com/article/jp-morgan-pegs-these-glove-makers-fair-value-half-their-market-price-says-supernormal-cycle?type=malaysia

Posted by jeremylin > 2020-12-12 01:59 | Report Abuse

Cant believe what Jp zhai wrote.....meaning to say others analyst (uob,pbb,myb,etc) make terrible mistake in their reports ?.....if want to uW also write reasonably la....

Posted by gemfinder > 2020-12-12 09:55 | Report Abuse

Joyce, i advise u beter u cut loss from being bankrap

Posted by gemfinder > 2020-12-12 09:57 |

Post removed.Why?

Posted by stockraider > 2020-12-12 10:17 | Report Abuse

Get ready for the coming big upside potential of insas in view of its growth potential, value rerating and big improvement in financial stock business mah....!!

Jump in & buy big b4 too late loh....!!

INSAS IS A MISUNDERSTOOD STOCK LOH....!!

IF U LOOK BACK AT INSAS FOR PAST 10 YEARS, IT HAS BEEN CREATING VALUE NON STOCK ALMOST EVERY YEAR WITH INCREASING SHAREHOLDER FUND MAH...!!

THATS THE REASONS WHY ITS NTA GROW FROM RM 1.00 SAY 10 YEARS AGO TO ALMOST RM 4.00- 5.00 AS AT NOW MAH...!!

INSAS BIGGEST WINNER LIKE INARI, CONTRIBUTE MORE THAN RM 1.4B MARKET CAP & SMALLER WINNER LIKE SENGENIC CAN CONTRIBUTE MORE THAN RM 60M LOH...!!

SMALL INVESTMENT LIKE OMESTI & DGSB ARE DOING EXTREMELY WELL LOH...!!

INSAS IS LIKE BERKSHIRE HATHAWAY BUSINESS MODEL LOH...!!

BUT UNLIKE BERSHIRE, ACTUALLY INSAS IS BETTER IT PAYS DIVIDEND BUT BERSHIRE DON'T PAY LOH...!!

THOSE INVESTING IN INSAS IS GETTING COMPOUND GROWTH RETURN AVERAGING 10 TO 12% PA EVERY YEAR LOH....!!

IF U BUY INSAS NOW U R PAYING RM 0.865 FOR A FAIR VALUE OF RM 4.00 IN INSAS LOH....!!

A GREAT INVESTMENT LOH...!!

BUT MOST EXCITING PART THIS INSAS IS GROWING WITH GOOD PROFITABILITY MAH!


Just look at the amazing growth track record of value creation of insas for the past 10 yrs

Sept 2020- Nta Rm 2.75

June 2019- Nta Rm 2.62

Dec 2018- Nta Rm 2.54

Dec 2017..Nta rm 2.49

Dec 2016 ...Nta Rm 2.18

Dec 2015..Nta Rm 1.96

Dec 2014..Nta rm 1.82

Dec 2013 nta..rm 1.71

Dec 2012 nta ..rm 1.51

Dec 2011 nta..rm 1.38

Dec 2010 nta...rm 1.22

Dec 2009 nta ..rm 1.14

INSAS IS GROWING STRONGLY MAH....ONLY THOSE PEOPLE DO NOT UNDERSTAND BERKSHIRE HATHWAY BUSINESS MODEL ARE SAYING INSAS HATHWAY BUSINESS MODEL ARE LOUSY LOH...!!

BUT INSAS BUSINESS MODEL ARE SAME SAME MAH, IN FACT INSAS GENERATE COMPOUND EARNINGS OF 12% PA SAME SAME AS BERKSHIRE WOH..!!...HOW COULD BE BERKSHIRE VERY GOOD & INSAS VERY BAD LEH ??

Posted by stockraider > 2020-12-12 10:31 | Report Abuse

Glove production capacity, they noted, is expected to grow 87% in the next three- to five years from this year’s, with 130 billion pieces per annum capacity to come from the big four glove makers of Top Glove, Hartalega, Kossan and Supermax Corp Bhd, and 20 billion pieces more from non-conventional players.

“The most worrying factor is oversupply, as we see not only significant capex plans from the big four producers but also from new players. While it is hard to measure the potential oversupply, we can take a leaf from the crude palm oil industry which saw a decade of oversupply post a supernormal cycle in the early 2000s,” they noted.

Additionally, glove makers' profitability is expected to be negatively affected by higher raw material prices and rising labour costs. "Pressure on foreign workers' treatment has and will continue to lift opex. Board members of certain glove producers have also asked for a raise in board fees. All these will add to higher opex and erode margins," they wrote.

Amid all this, they think the upside potential for glove stocks may be capped, with retail and foreign participation having reached all-time highs.

Malaysia’s government linked funds are the only hope to lift the sector, they wrote, yet they have also been trimming their exposure recently.

"The market cap of the top-four producers is RM170 billion, equal to 66% of local non-government-linked funds’ AUM (asset under management). Our proprietary analysis shows most funds have exposure in gloves and their cash holdings are low. To date, local mutual funds have invested 11% of AUM in gloves. Retail and foreign participation are at all-time highs. It is thus difficult to find incremental dollars to drive this sector higher," the note read.

Meanwhile, they noted that Top Glove and Hartalega's capital management decisions have not been optimal for creating value for shareholders due to the focus on accelerating capex via cash to support capacity growth.

Posted by Morpheus61 > 2020-12-12 10:34 | Report Abuse

When these Investment Bank's are done screwing the retailers on the so called " Recovery Stocks", they will come back to screw us on the Glove stocks again.

PUT A CREDIBILITY RATING ON THESE INVESTMENT BANKS. ....Done by the Retail Investors :)

Posted by stockraider > 2020-12-12 10:35 | Report Abuse

THE DEMAND FOR GLOVES ALREADY PEAKED....THE NEXT STAGE IS FALLING DEMAND, OVERSUPPLY & FALLING PROFIT & SHARE PRICE LOH...!!

RUN B4 TOO LATE LOH...!!

Its analysts Jeffrey Ng and YY Cheah, in a note to clients today, said they expect glove prices to weaken in the second half of next year.

"Global testing trends have also plateaued, which ought to ease current supply tightness. JP Morgan’s proprietary fund flow analysis indicates the glove sector is a crowded trade, implying significant downside momentum. Near-term concerns on rising costs, plus long-term overcapacity risk, spell downside risks. Once Malaysia lifts the short selling ban, downward pressure could be amplified," they wrote.

In particular, they noted that 13 of 17 highly populated nations’ testing trends have started to trend downwards from their peaks since the end of September. This, they wrote, may be an early indication that glove prices too have peaked, and similarly for producers’ profits and share prices.

Posted by Morpheus61 > 2020-12-12 10:40 | Report Abuse

Stokraider, honestly, which Invest Bank do you work for ?

Posted by stockraider > 2020-12-12 10:45 | Report Abuse

LISTEN DON BE SOHAI...HOLDING ON A FALLING KNIFE ON GLOVES STOCK LOH...!!

RUN 1ST....U CAN ALWAYS REVISIT GLOVES AT A MUCH LOWER PRICE AT LATER MAH...!!

RUN EARLY LOSSES WILL BE MUCH LESSER NOW MAH...!!

Posted by Morpheus61 > 2020-12-12 10:46 | Report Abuse

I have to hand it to JP Morgan for that absolutely IMPECCABLE TIMING of that TP. Monday to Thursday is the VWAP calculation for MacQuaire C69.

BRILLIANT JP MORGUE

Posted by Joyce Lee > 2020-12-12 10:57 | Report Abuse

Gemfinder don be stupid la , u tot all of us all in at glove counter meh ? Previously ad earn in glove la , like u meh , just condemn but never earn in glove

Posted by stockraider > 2020-12-12 10:58 | Report Abuse

MKT ALWAYS LOOK BEYOND CURRENT ORDERS & PROFIT MAH...!!

RUN B4 TOO LATE LOH...!

BEGINNING OF THE GLOVES CRASH COMING MAH...!!

Posted by Morpheus61 > Dec 12, 2020 10:53 AM | Report Abuse

When the Orders are booked for most Glove manufacturers up to end 2021, how can the ASP drop next year. The spill-over until those orders are fulfilled will cause a furthur backlog. Then how ?

Posted by Morpheus61 > 2020-12-12 10:59 | Report Abuse

Oh so MARKET only looks at the TIMING of the WARRANT EXPIRY ?

Posted by stockraider > 2020-12-12 11:06 | Report Abuse

NO ONE IS MIGHTY ENOUGH TO FIGHT THE MARKET, NOT EVEN TAN SRI WEE TOP GLOVES BOSS LOH....!!

RUN B4 TOO LATE LOH...!!

TSUNAMI IS COMING FOR GLOVES LOH...!!

MKT ALWAYS LOOK BEYOND CURRENT ORDERS & PROFIT MAH...!!

RUN B4 TOO LATE LOH...!

Posted by Master123 > Dec 12, 2020 11:00 AM | Report Abuse

Halo..JP Morgan do u know how to calculate PE n EPS. And Tan Sri oledi confirmed that 2021 order was full. Yr statement totally not make sense. Probably JP Morgan like those penny stock or companies make loss in every quarter.

Posted by Utradenow > 2020-12-12 11:20 | Report Abuse

Repeatedly up and down... any prospects?

Posted by jeremylin > 2020-12-12 11:21 | Report Abuse

https://finance.yahoo.com/news/rubber-gloves-market-size-reach-160000542.html?guccounter=1&guce_referrer=aHR0cHM6Ly9rbHNlLmkzaW52ZXN0b3IuY29tLw&guce_referrer_sig=AQAAAFFPMLgK1Q7K84gmKMO4Evq9sWuUYEUV7mEO8yfruu4_C4yTMZ_xiOT442w-ZJ0XJqLW2A7iz6hazcvcygjudqc8AN5r0bTDm0muRTpPpKPCfEitDmQSbUQHnopd4H2bFCLM4qBBokNKInfm0zurfO26ofyXNyZ2HRUdMBq3ghbG

Posted by gemfinder > 2020-12-12 11:36 |

Post removed.Why?

Posted by Joyce Lee > 2020-12-12 12:14 | Report Abuse

All you can do is condemn and cursing others because u never earn in glove counter kikiki

Posted by stockraider > 2020-12-12 12:16 | Report Abuse

IT IS BETTER TO BE FEARFUL THAN HOPEFUL LOH...!!

TSUNAMI GLOVES CRASH IS COMING LOH...!!

Posted by sign's uncle > Dec 12, 2020 12:13 PM | Report Abuse

i believe foreign funds will really come in a big way in 2021 especially to gloves. good luck

Posted by Joyce Lee > Dec 12, 2020 12:14 PM | Report Abuse

All you can do is condemn and cursing others because u never earn in glove counter kikiki

Posted by Morpheus61 > 2020-12-12 12:16 | Report Abuse

stockraider, go brush your teeth

Posted by Morpheus61 > 2020-12-12 12:17 | Report Abuse

You stink

Posted by stockraider > 2020-12-12 12:19 |

Post removed.Why?

Posted by NPRA1985 > 2020-12-12 17:15 | Report Abuse

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Posted by xcu843 > 2020-12-12 18:09 | Report Abuse

Vaccine approved only for emergency use, not all the country will follow United States. It still got some risk. Health care product like glove and face mask still can survive.

Posted by NPRA1985 > 2020-12-13 17:46 | Report Abuse

Bahrain Approves China’s Sinopharm Covid-19 Vaccine

Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the coronavirus, about a week after the United Arab Emirates registered the Chinese-made vaccine.

“Results from Phase III clinical trials showed an 86% efficacy rate, a 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of Covid-19,” the National Health Regulatory Authority said in a statement Sunday.

Bahrain has participated in phase III clinical trials, in which more than 7,700 volunteers signed up. Bahrain had previously authorized the emergency use of the vaccine, which was provided to frontline workers in contact with coronavirus patients.

The UAE registered the Sinopharm vaccine after finding it had a 86% efficacy rate, paving the way for a full public use and allowing for a re-opening of the Gulf nation’s economy.

Egypt plans to start the process of inoculation against the coronavirus after receiving the first shipments of Sinopharm vaccine.

https://www.bloomberg.com/news/articles/2020-12-13/bahrain-approves-china-s-sinopharm-covid-19-vaccine

https://abcnews.go.com/Health/wireStory/bahrain-approves-chinese-covid-19-vaccine-74699175

Posted by NPRA1985 > 2020-12-13 18:21 | Report Abuse

Govt to increase Covid-19 vaccine purchase to cover 60%-70% of M'sians — PM

The government has plans to increase its purchase of the Covid-19 vaccine to cover the immunisation needs of about 60%-70% of Malaysians compared with 30% currently.

Prime Minister Tan Sri Muhyiddin Yassin said this was because some nations had purchased doses exceeding their population.

“As for Malaysia, we have already got 30%. I have instructed Health Minister Datuk Seri Dr Adham Baba along with [Science, Technology and Innovation Minister] Khairy Jamaluddin Abu Bakar to negotiate and increase it from 30% to 60% or 70%.

https://www.theedgemarkets.com/article/govt-mulls-increasing-covid19-vaccine-purchase-30-6070-meet-msians-immunisation-needs-%E2%80%94-pm

Posted by Shadows > 2020-12-13 19:57 | Report Abuse

Glove share will peak by end Dec. Vaccine news is still inmature and many countries will start lock down again during winter.

Posted by NPRA1985 > 2020-12-13 20:22 | Report Abuse

COVID-19 vaccine is permissible for Muslim use, preservation of life is key consideration: MUIS

SINGAPORE: The Islamic Religious Council of Singapore (MUIS) said on Sunday (Dec 13) that it "holds the position that a COVID-19 vaccine is permissible for Muslim use".

"We would advise and encourage Muslims to be vaccinated once it is available and when the vaccine has been medically authorised as safe and effective, as this is a basic necessity to protect lives in the context of a global pandemic," said MUIS.

The council made its religious position on the vaccine known in a media release.

It said that the objectives of introducing a COVID-19 vaccine and the processes involved in producing vaccines are "largely aligned to established Islamic principles and values".

Islamic jurisprudence places great importance on the sanctity and safety of human life and the protection of livelihoods, it said.

Efforts to protect human life from any form of danger and harm, such as the development of vaccines, are therefore highly encouraged in Islam, it added.

https://www.channelnewsasia.com/news/singapore/covid-19-vaccine-muis-permissible-for-muslim-use-halal-13762806

Posted by ryanlcc > 2020-12-14 09:26 | Report Abuse

Shadow: Agree...tadak takut....
Discounted Rubberex....